Cynosure Inc announces the recent FDA clearance of its PicoSure energy delivery system for tattoos and pigmented lesions.
Considered the world’s first aesthetic picosecond laser, the PicoSure system contains a new 1064-nm laser delivery system, which is able to remove the full color spectrum of tattoo inks with fewer treatments.
The PicoSure is especially designed for the removal of dark and black inks. The laser complements the 755-nm wavelength and Cynosure’s FOCUS Lens Array proprietary system. In addition to removing tattoos, the lasers can also treat acne scars, wrinkles, and pigmented lesions, according to a release from Westford, Mass-based Cynosure Inc.
“PicoSure is widely recognized by aesthetic practitioners for its unsurpassed clinical efficacy and proven performance,” says Michael Davin, CynoSure CEO, in the release. “With the FDA clearance of the 1064-nm Laser Delivery System, we believe our picosecond technology has the broadest range of clearances on the market. The new 1064 nm wavelength builds on our aesthetic industry leadership and expands PicoSure’s versatility for tattoos, pigmentation, and skin revitalization.”
The PicoSure clinical experience was the subject of 11 oral abstracts and three ePosters at an American Society for Laser Medicine & Surgery Annual Conference in Boston. At the conference, researchers also reported on studies proposing PicoSure as a treatment for melasma, a hyperpigmentation commonly seen in women.
[Source(s): Cynosure Inc, PR Newswire]